| Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey L Pagano, J Salmanton-García, F Marchesi, O Blennow, ... Blood, The Journal of the American Society of Hematology 140 (26), 2773-2787, 2022 | 77 | 2022 |
| Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies: an EPICOVIDEHA survey report O Blennow, J Salmanton‐García, P Nowak, F Itri, J Van Doesum, ... American journal of hematology 97 (8), E312-E317, 2022 | 63 | 2022 |
| Improved clinical outcome of COVID‐19 in hematologic malignancy patients receiving a fourth dose of anti‐SARS‐CoV‐2 vaccine: an EPICOVIDEHA report J Salmanton‐García, F Marchesi, A Glenthøj, YM Bilgin, J Van Praet, ... Hemasphere 6 (11), e789, 2022 | 33 | 2022 |
| Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry J Salmanton-García, F Marchesi, MG da Silva, F Farina, J Dávila-Valls, ... EClinicalMedicine 58, 2023 | 25 | 2023 |
| Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies F Magyari, LI Pinczés, E Páyer, K Farkas, S Ujfalusi, Á Diószegi, M Sik, ... Annals of hematology 101 (10), 2337-2345, 2022 | 23 | 2022 |
| Interim PET/CT in diffuse large B-cell lymphoma may facilitate identification of good-prognosis patients among IPI-stratified patients R Nyilas, B Farkas, RR Bicsko, F Magyari, LI Pinczes, A Illes, L Gergely International Journal of Hematology 110, 331-339, 2019 | 17 | 2019 |
| Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings G Rossi, J Salmanton-García, C Cattaneo, F Marchesi, J Dávila-Valls, ... International Journal of Infectious Diseases 137, 98-110, 2023 | 13 | 2023 |
| Real-world efficacy of brentuximab vedotin plus bendamustine as a bridge to autologous hematopoietic stem cell transplantation in primary refractory or relapsed classical … LI Pinczés, R Szabó, Á Illés, D Földeák, K Piukovics, Á Szomor, L Gopcsa, ... Annals of Hematology 99, 2385-2392, 2020 | 12 | 2020 |
| A pharmacokinetic evaluation of ropeginterferon alfa-2b in the treatment of polycythemia vera Á Illés, LI Pinczés, M Egyed Expert opinion on drug metabolism & toxicology 17 (1), 3-7, 2021 | 9 | 2021 |
| Young adults diagnosed with Hodgkin lymphoma are at risk of relapsing late: a comprehensive analysis of late relapse in Hodgkin lymphoma L Pinczés, Z Miltényi, Á Illés Journal of Cancer Research and Clinical Oncology 144, 935-943, 2018 | 7 | 2018 |
| Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022 J Salmanton-García, F Marchesi, F Farina, B Weinbergerová, F Itri, ... EClinicalMedicine 71, 2024 | 6 | 2024 |
| Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey T Lahmer, J Salmanton-García, F Marchesi, S El-Ashwah, M Nucci, ... Infection, 1-17, 2024 | 6 | 2024 |
| Simultaneous onset of haematological malignancy and COVID: an epicovideha survey C Cattaneo, J Salmanton-García, F Marchesi, S El-Ashwah, F Itri, ... Cancers 14 (22), 5530, 2022 | 5 | 2022 |
| Transition Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma–Our Histopathological and Clinical Experience With Patients With Intermediate Lymphoma Z Simon, B Virga, L Pinczés, G Méhes, Z Miltényi, S Barna, R Szabó, ... Pathology and Oncology Research 27, 2021 | 5 | 2021 |
| How the epidemiology of Hodgkin lymphoma changed in Debrecen, Hungary L Pinczés, Z Miltényi, Á Jóna, F Magyari, Á Illés Medical Research Archives 4 (6), 2016 | 5 | 2016 |
| 18 Combined prognostic role of TARC and interim F-FDG PET/CT in patients with Hodgkin lymphoma-real world observational study MD Zsolt Fejes, B Nagy Jr Hellenic Journal of Nuclear Medicine 25 (2), 125-131, 2022 | 4 | 2022 |
| Pulmonary Toxicity of Hodgkin Lymphoma Treatment: A Prospective Single-Center Study A Jona, Z Miltenyi, L Pinczes, P Kerek, N Bittner, M Szilasi, S Barna, ... Journal of Hematology 10 (6), 266, 2021 | 4 | 2021 |
| The impact of autoimmune cytopenias on the clinical course and survival of Hodgkin lymphoma LI Pinczés, R Szabó, Z Miltényi, Á Illés International Journal of Hematology 113, 175-182, 2021 | 4 | 2021 |
| Treatment of acute myeloid leukemia–a single center experience (2007–2013) A Selmeczi, M Udvardy, Á Illés, B Telek, A Kiss, P Batár, G Reményi, ... Orvosi Hetilap 155 (17), 653-658, 2014 | 4* | 2014 |
| Improved survival of autologous stem cell transplantation in primary refractory and relapsed Hodgkin lymphoma in the brentuximab vedotin era—real-world data from Hungary K Husi, R Szabó, LI Pinczés, D Földeák, R Dudley, Á Szomor, B Koller, ... Annals of Hematology 102 (9), 2555-2563, 2023 | 3 | 2023 |
